May 5 (Reuters) - Abbvie Inc ABBV.N :
* ABBVIE RECEIVES HEALTH CANADA APPROVAL FOR THE COMBINATION OF VENCLEXTA® (VENETOCLAX) WITH OBINUTUZUMAB FOR PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
May 5 (Reuters) - Abbvie Inc ABBV.N :
* ABBVIE RECEIVES HEALTH CANADA APPROVAL FOR THE COMBINATION OF VENCLEXTA® (VENETOCLAX) WITH OBINUTUZUMAB FOR PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA